Accelerated Ventures invests £3.5m in Biosignatures
London-based Accelerated Ventures has invested £3.5m in Newcastle-headquartered biotechnology startup Biosignatures.
More on Expansion
Khosla leads $9m series-A extension for Sword Health
Vesalius Biocapital, Green Innovations, Founders Fund and Faber Ventures also take part in the round
Goldman Sachs et al. in $55m round for Jumo
Odey Asset Management and Leapfrog Investments also back the round
Georgian leads $25m series-C for Tractable
Series-C funding round nearly doubles the total funds raised by the company to $55m
Frog leads £7m round for SHE Software
Existing investor the Northern VCTs, managed by Mercia, also participated
Latest News
Checkout.com acquires VC-backed ProcessOut
Insight Partners and DST Global led a $230m series-A funding round for Checkout.com last year
Alvia buys majority stake in Hamburg Care
Acquisition of a majority stake in the Germany-based care provider marks the firm's first investment
MML-backed Learning Curve nearing sale - report
Agilitas, investing from its 2015 fund, is said to be one of the final bidders in the process
Palatine promotes six
Firm has promoted James Gregson, Kieran Lawton and James Winterbottom to senior investment director